Cargando…
Molecular Docking Identifies 1,8-Cineole (Eucalyptol) as A Novel PPARγ Agonist That Alleviates Colon Inflammation
Inflammatory bowel disease, comprising Crohn’s disease (CD) and ulcerative colitis (UC), is often debilitating. The disease etiology is multifactorial, involving genetic susceptibility, microbial dysregulation, abnormal immune activation, and environmental factors. Currently, available drug therapie...
Autores principales: | Venkataraman, Balaji, Almarzooqi, Saeeda, Raj, Vishnu, Bhongade, Bhoomendra A., Patil, Rajesh B., Subramanian, Veedamali S., Attoub, Samir, Rizvi, Tahir A., Adrian, Thomas E., Subramanya, Sandeep B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094723/ https://www.ncbi.nlm.nih.gov/pubmed/37047133 http://dx.doi.org/10.3390/ijms24076160 |
Ejemplares similares
-
α-Bisabolol Mitigates Colon Inflammation by Stimulating Colon PPAR-γ Transcription Factor: In Vivo and In Vitro Study
por: Venkataraman, Balaji, et al.
Publicado: (2022) -
Thymoquinone, a Dietary Bioactive Compound, Exerts Anti-Inflammatory Effects in Colitis by Stimulating Expression of the Colonic Epithelial PPAR-γ Transcription Factor
por: Venkataraman, Balaji, et al.
Publicado: (2021) -
Gastroprotective Mechanisms of the Monoterpene 1,8-Cineole (Eucalyptol)
por: Rocha Caldas, Germana Freire, et al.
Publicado: (2015) -
Cis-Nerolidol Inhibits MAP Kinase and NF-κB Signaling Pathways and Prevents Epithelial Tight Junction Dysfunction in Colon Inflammation: In Vivo and In Vitro Studies
por: Raj, Vishnu, et al.
Publicado: (2023) -
Nerolidol Mitigates Colonic Inflammation: An Experimental Study Using both In Vivo and In Vitro Models
por: Raj, Vishnu, et al.
Publicado: (2020)